Skip to main content
. 2021 May 13;9(3):e00730. doi: 10.1002/prp2.730

FIGURE 1.

FIGURE 1

Impact of atorvastatin on trough and peak anti‐Xa activity in AF patients on long‐term rivaroxaban/apixaban therapy